Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04886622
Title A Study of DT2216 in Relapsed/Refractory Malignancies
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Dialectic Therapeutics, Inc
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Northwestern University Chicago Illinois 60611 United States Details
Mary Crowley Cancer Research Dallas Texas 75230 United States Details
Mays Cancer Center San Antonio Texas 78222 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field